204 related articles for article (PubMed ID: 29246438)
1. Nano-scale and molecular-level understanding of wet-milled indomethacin/poloxamer 407 nanosuspension with TEM, suspended-state NMR, and Raman measurements.
Kuroiwa Y; Higashi K; Ueda K; Yamamoto K; Moribe K
Int J Pharm; 2018 Feb; 537(1-2):30-39. PubMed ID: 29246438
[TBL] [Abstract][Full Text] [Related]
2. Effect of wet milling process on the solid state of indomethacin and simvastatin.
Sharma P; Denny WA; Garg S
Int J Pharm; 2009 Oct; 380(1-2):40-8. PubMed ID: 19576976
[TBL] [Abstract][Full Text] [Related]
3. Direct evaluation of molecular States of piroxicam/poloxamer nanosuspension by suspended-state NMR and Raman spectroscopies.
Hasegawa Y; Higashi K; Yamamoto K; Moribe K
Mol Pharm; 2015 May; 12(5):1564-72. PubMed ID: 25849345
[TBL] [Abstract][Full Text] [Related]
4. Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility.
Colombo M; Minussi C; Orthmann S; Staufenbiel S; Bodmeier R
Eur J Pharm Biopharm; 2018 Apr; 125():159-168. PubMed ID: 29371046
[TBL] [Abstract][Full Text] [Related]
5. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
[TBL] [Abstract][Full Text] [Related]
6. Transition from Amorphous Cyclosporin A Nanoparticles to Size-Reduced Stable Nanocrystals in a Poloxamer 407 Solution.
Chen Z; Higashi K; Ueda K; Moribe K
Mol Pharm; 2022 Jan; 19(1):188-199. PubMed ID: 34843257
[TBL] [Abstract][Full Text] [Related]
7. Spectroscopic Investigation of the Formation and Disruption of Hydrogen Bonds in Pharmaceutical Semicrystalline Dispersions.
Van Duong T; Reekmans G; Venkatesham A; Van Aerschot A; Adriaensens P; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2017 May; 14(5):1726-1741. PubMed ID: 28363028
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle agglomerates of indomethacin: The role of poloxamers and matrix former on their dissolution and aerosolisation efficiency.
Malamatari M; Somavarapu S; Bloxham M; Buckton G
Int J Pharm; 2015 Nov; 495(1):516-526. PubMed ID: 26364709
[TBL] [Abstract][Full Text] [Related]
9. Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions.
Zhao Z; Katai H; Higashi K; Ueda K; Kawakami K; Moribe K
Mol Pharm; 2019 May; 16(5):2184-2198. PubMed ID: 30925218
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles.
La SB; Okano T; Kataoka K
J Pharm Sci; 1996 Jan; 85(1):85-90. PubMed ID: 8926590
[TBL] [Abstract][Full Text] [Related]
11. Selective Acceleration of Crystal Growth of Indomethacin Polymorphs by Low-Concentration Poly(ethylene oxide).
Shi Q; Zhang J; Zhang C; Jiang J; Tao J; Zhou D; Cai T
Mol Pharm; 2017 Dec; 14(12):4694-4704. PubMed ID: 29125764
[TBL] [Abstract][Full Text] [Related]
12. Continuous Monitoring of the Agglomeration and Sedimentation of Indomethacin Nanosuspensions Using T
Ono T; Okada K; Tsuchiya M; Hayashi Y; Kumada S; Onuki Y
Chem Pharm Bull (Tokyo); 2023; 71(8):665-669. PubMed ID: 37532537
[TBL] [Abstract][Full Text] [Related]
13. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
14. Melt Crystallization of Indomethacin Polymorphs in the Presence of Poly(ethylene oxide): Selective Enrichment of the Polymer at the Crystal-Liquid Interface.
Zhang J; Shi Q; Guo M; Liu Z; Cai T
Mol Pharm; 2020 Jun; 17(6):2064-2071. PubMed ID: 32298128
[TBL] [Abstract][Full Text] [Related]
15. Dissolution study of nanocrystal powders of a poorly soluble drug by UV imaging and channel flow methods.
Sarnes A; Østergaard J; Jensen SS; Aaltonen J; Rantanen J; Hirvonen J; Peltonen L
Eur J Pharm Sci; 2013 Nov; 50(3-4):511-9. PubMed ID: 23999036
[TBL] [Abstract][Full Text] [Related]
16. X-ray Absorption Near-Edge Spectroscopy Analysis of Indomethacin in Crystalline Forms and in Amorphous Solid Dispersions.
Suzuki H; Iwata M; Ito M; Noguchi S
Mol Pharm; 2021 Sep; 18(9):3475-3483. PubMed ID: 34372659
[TBL] [Abstract][Full Text] [Related]
17. Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction.
Chauhan H; Kuldipkumar A; Barder T; Medek A; Gu CH; Atef E
Pharm Res; 2014 Feb; 31(2):500-15. PubMed ID: 24122167
[TBL] [Abstract][Full Text] [Related]
18. Fabrication of drug-loaded edible carrier substrates from nanosuspensions by flexographic printing.
Palo M; Kolakovic R; Laaksonen T; Määttänen A; Genina N; Salonen J; Peltonen J; Sandler N
Int J Pharm; 2015 Oct; 494(2):603-610. PubMed ID: 25601198
[TBL] [Abstract][Full Text] [Related]
19. Systematic screening of different surface modifiers for the production of physically stable nanosuspensions.
Lestari ML; Müller RH; Möschwitzer JP
J Pharm Sci; 2015 Mar; 104(3):1128-40. PubMed ID: 25630623
[TBL] [Abstract][Full Text] [Related]
20. The Scalability of Wet Ball Milling for The Production of Nanosuspensions.
Lestari MLAD; Müller RH; Möschwitzer JP
Pharm Nanotechnol; 2019; 7(2):147-161. PubMed ID: 30931866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
